The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. (2011)

First Author: Royston P
Attributed to:  MRC Clinical Trials Unit as the London Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.4274

PubMed Identifier: 21611958

Publication URI: http://europepmc.org/abstract/MED/21611958

Type: Journal Article/Review

Volume: 30

Parent Publication: Statistics in medicine

Issue: 19

ISSN: 0277-6715